English
Español

(805) 483 1185

Participate in a study!

Linkedin-in Instagram Facebook-f
01 Fomat_Logo_Website-min
proud-partner-HCI-V6
  • Home
  • About Us
  • For Sponsors & CROs
    • Services For Sponsors & CROs
    • Our Capabilities
      • eClinical Trials
      • NASH Capabilities
      • COVID Solutions
      • Vaccine Capabilities
  • For Sites
  • For Patients
    • Educational Program
    • Educational Program: Fatty Liver Test
    • Healthy Volunteers
    • About Clinical Trials
      • What are Clinical Trials
      • Why Participate in a Clinical Trial
      • Clinical Trials FAQs
      • Clinical Trials Glossary
    • Active Studies
  • News & Updates
  • Contact FOMAT
  • │Fomat LatAm

Home » Blogs & Updates » Page 4

Posts in category: Blogs & Updates

vaccine

Designing a blood test that can predict lifespan

August 27, 2019
by fomat_medical

The ability to predict how long someone is likely to live would help doctors tailor treatment plans. A new study looking at biomarkers in the blood concludes that more accurately estimating mortality might soon be possible. As it stands, doctor ...

Read More
0
Covid-19

Harvard Chemists’ Breakthrough in Synthesis Advances a Potent Anti-Cancer Agent

August 22, 2019
by fomat_medical

 Harvard University chemists have achieved what a new paper calls a "landmark in drug discovery" with the synthesis of halichondrin. Known to be a potent anti-cancer agent in mouse studies, and found naturally in sea sponges. ...

Read More
0
Ovary

A ‘One-Two Punch’ to Wipe Out Cancerous Ovarian Cells

July 23, 2019
by fomat_medical

Researchers from the University of Montreal Hospital Research Centre (CRCHUM) have developed a two-step combination therapy to destroy cancer cells. In a study published in the journal Nature Communications, they show the superior therapeutic e ...

Read More
0
Office Medical Building Photo | CROs Site

What Do Cros and Sponsor Consider When Selecting a Site?

June 24, 2019
by fomat_medical

Within the pharmaceutical industry, 45% of clinical trials are completed late, or 70%-80% of studies are delayed or do not meet their timelines. Due to these reasons, one of the main goals for a CRO is to create a mitigating strategy that overcomes t ...

Read More
0
Harvard Chemists' Breakthrough in Synthesis Advances a Potent Anti-Cancer Agent

Chemists’ breakthrough in synthesis advances a potent anti-cancer agent

June 17, 2019
by fomat_medical

It’s a feat three decades in the making: Harvard University chemists have achieved what a new paper calls a “landmark in drug discovery” with the total synthesis of halichondrin. Known to be a potent anti-cancer agent in mouse studies, and found n ...

Read More
0
New Vulnerability Found in Major Human Viruses

New Vulnerability Found in Major Human Viruses

June 14, 2019
by fomat_medical

The Discovery of a new feature of a large class of pathogenic viruses may allow the development of new antiviral medications for the common cold, polio, and other illnesses, according to a new study publishing June 11 in the open-access journal ...

Read More
0
Blausen_0246_ColorectalCancer

Delays Lead to Late-Stage Diagnosis of Young People With Colorectal Cancer

May 30, 2019
by fomat_medical

The incidence of early-onset colorectal cancer has increased by nearly 50 percent in the last 30 years. A University of Colorado Cancer Center study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago aimed t ...

Read More
0
Colorectal Cancer

Novel Vaccine for colorectal cancer Shows Positive Phase I Results

May 6, 2019
by fomat_medical

A new colorectal cancer vaccine showed positive results in phase 1 clinical trial to demonstrate that the approach is safe. The patients treated had no signs of serious adverse events and samples of their blood contai ...

Read More
Diabetes

Novel Therapies Slow CKD Progression in Patients With Diabetes

April 29, 2019
by fomat_medical

Treatment options for patients with CKD are limited and often determined by the etiology of the CKD. RAAS blockade (ACE inhibitors or angiotensin receptor blockers) has so far been the only therapeutic intervention which has bee ...

Read More
liver

A Tiny Cry for Help From Inside the Liver Could Lead to Better Treatment

April 17, 2019
by fomat_medical

But when something comes along that badly injures enough of those cells—such as a liver-damaging overdose of pain medicine—this vital work can come to a screeching halt. With few good treatment options available, more than 2,00 ...

Read More
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • ...
  • 42
  • Next
  • Last

Recent Posts

  • Innovating our services alongside FOMAT’s Research Ambulance!
  • We are hiring a Project Manager! 
  • National Endometriosis Awareness Month
  • Rare Disease Day
  • American Heart Month

Categories

  • Blogs & Updates
  • Company Updates
  • eClinical Trials Category
  • Social Media
  • Uncategorized
  • Whitepapers

Upcoming Events

Bio Convention

June 13 - 16th

San Diego, CA

 

 

Contact Us

FOMAT Medical Research INC,
300 South A Street Suite 201 Oxnard, CA 93030
(805) 483 1185
Trial Information: [email protected]
General Information: [email protected]
  • Review us on Google
  • Review us on Yelp

Site Map | Privacy Policy

Shopping Basket